Clinical Trials Browser

Phase 2 × Graft vs Host Disease × Decitabine × Clear all

NCT03771222 2018-12-13

Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies

Phase 2 Unknown

Graft vs Host Disease, Recurrence